Immunoconjugate definition
Examples of Immunoconjugate in a sentence
For clarification, the royalty as described in Section 2.11(d)(i), to be negotiated in good faith by the Parties, shall apply if the sole-developing Party’s Patent Rights and Know How are practiced or used with respect to the Solely Developed Immunoconjugate as described herein.
Where such Licensed Refused Sanofi Candidate is an Immunoconjugate, then *****************************.
Where such Licensed Refused Sanofi Candidate is an Immunoconjugate, ********************.
With respect to any Failed MTC each Party hereby grants to the other a non-transferable, non-exclusive, worldwide, royalty-bearing (in accordance with Section 4.4 herein) license, with the right to sublicense, and with respect to Regeneron Target IP and Sanofi Target IP (as the case may be) solely to make, have made, use, sell, offer to sell and import IFMs. For the avoidance of doubt, such a license shall not include rights to any underlying Immunoconjugate technology owned by the licensing Party.
If the JRC decides to include the Solely Developed Immunoconjugate into the Discovery Program, then the Solely Developed Immunoconjugate shall be considered a Product Candidate and become a Licensed Product under the License and Collaboration Agreement.
Both Parties’ representatives on the JRC must agree to develop Immunoconjugates in the Discovery Program, including the type of Immunoconjugate technology to be used in the Discovery Program, and any disagreements related to such decisions shall be referred to the Parties’ Executive Officers with neither Party’s Executive Officer having the deciding vote.
Except as set forth in SCHEDULE 3.18, neither the Company nor any of its Subsidiaries owns or holds, directly or indirectly, any capital stock or equity interest in any other Person (other than a Subsidiary).
Where such Licensed Refused Sanofi Candidate is an Immunoconjugate, *********************.
In addition to the ****************** described in subsection (i) immediately above, a royalty payment of ************* shall apply for a Licensed Refused Sanofi Candidate in such countries where, and for so long as, ****************** (plus any additional royalty referred to in Section 2.11(d)(i), if applicable, for a Licensed Refused Sanofi Candidate that is an Immunoconjugate using Sanofi’s Immunoconjugate technology, for so long as it incorporates such technology).
The sole-developing Party shall propose to the JRC the Solely Developed Immunoconjugate for inclusion in the Discovery Program when the Solely Developed Immunoconjugate has completed IND Preparation (unless the naked Antibody directed against the same Target as the Solely Developed Immunoconjugate is an IFM), and shall do so by submitting to the JRC a copy of the IND filing following the IND filing date.